Question 1

Does Cresset own CLDX stock?

Accepted Answer

No. Cresset exited its CLDX (Celldex Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 457,666 shares worth $15.3M.

Question 2

How many shares of CLDX does Cresset own?

Accepted Answer

None since Q3 2021, when Cresset exited the position. Its Q2 2021 13F listed 457,666 shares worth $15.3M.

Question 3

What is Cresset's CLDX position worth?

Accepted Answer

Cresset's CLDX position was worth $15.3M in its Q2 2021 13F, before the exit in Q3 2021.

Question 4

Is Cresset buying or selling CLDX?

Accepted Answer

In Q3 2021, Cresset exited its entire CLDX position.

Question 5

When did Cresset first buy CLDX?

Accepted Answer

Cresset first reported CLDX in its Q2 2019 13F and listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2021-Q3 Latest	Exited	0	-100.0%	$0	0.0%	$53.99	0
2021-Q2	Unchanged	457,666	0.0%	$15.3M	0.2%	$33.44	0
2021-Q1	Unchanged	457,666	0.0%	$9.4M	0.1%	$20.60	0
2020-Q4	Unchanged	457,666	0.0%	$8M	0.1%	$17.52	0
2020-Q3	Unchanged	457,666	0.0%	$6.8M	0.1%	$14.83	0
2020-Q2	Unchanged	457,666	0.0%	$6M	0.1%	$13.00	0
2020-Q1	Unchanged	457,666	0.0%	$760,000	0.0%	$1.66	0
2019-Q4	Unchanged	457,666	0.0%	$1M	0.0%	$2.23	0
2019-Q3	Unchanged	457,666	0.0%	$975,000	0.0%	$2.13	0
2019-Q2	New	457,666	-	$1.2M	0.0%	$2.68	35